Optimization of sample preparation was carried out in order to identify the most appropriate matrix preparation and deposition method for the analysis of bacteria.
In this overview, we focused on bladder acellular matrix preparation techniques and factors that have impact on BAM structure, porosity, and mechanical properties.
Examples include bulking agents and meshes used to treat urinary incontinence, pelvic organ prolapse, and hernias, breast reconstruction implants, skin substitutes, and wound dressings for burn injuries and diabetic foot ulcers and injectable extracellular matrix preparations for muscle repair following sports or other traumatic injuries.
We found the presence of Dp71, β-dystroglycan, nNOS, β-sarcoglycan, α/β syntrophin, α1-dystrobrevin and β-dystrobrevin in the nuclear matrix protein fractions and in situ nuclear matrix preparations from HeLa cells.
The FDA materials available for that investigation appear to be partial outcome data from a subset of industry funded studies evaluating Infuse/LT-CAGE, Infuse/MASTERGRAFT, and AMPLIFY rhBMP-2 matrix preparations.
Calmodulin and two specific Ca2+-dependent calmodulin-binding proteins were found to be associated with matrix preparations.
We also addressed the requirement for Topoisomerase II, a major component of nuclear matrix preparations, for maintenance of chromosome architecture.
Preparations using lithium-3,5-iodosalicylate (LIS) extraction are referred to as nuclear scaffolds, while extraction with 2 M NaCl are referred to as nuclear matrix preparations.
Nuclear matrix preparations were done as described [ 43].
Average matrix fluorescence outside the cell bodies was set to 500 arbitrary units to allow the local difference values to be compared between extracellular matrix preparations [ 19].
